1. FDA approval letter of pregabalin for the management of neuropathic pain associated with diabetic peripheral neuropathy. Department of Health and Human Services,2006
2. FDA approval letter of pregabalin for the management of postherpetic neuralgia,2006
3. FDA approval letter of pregabalin as adjunctive therapy for adult patients with partial onset seizures,2006
4. Pfizer's Lyrica approved for the treatment of generalized anxiety disorder in Europe,2006
5. Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C;Fehrenbacher;Pain,2003